TABLE III.
Clinicopathologic Characteristics of 12 10-Year Survivors After Resection of ACC
| Age (years) |
Sex | Hormonal secretion | Size (cm) |
TNM | Margins | Adjuvant therapy |
Recurrence | DFI (months) |
Treatment for Recurrence |
Status | Survival (months) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 46 | F | Nonsecreting | 15.0 | T2NxM0 | R0 | None | No | NA | NA | NED | 143 |
| 49 | M | Nonsecreting | NR | NR | R0 | None | No | NA | NA | NED | 220 |
| 73 | F | Nonsecreting | 4.5 | T1NxM0 | R0 | None | Lung (distant) | 108.8 | None | DOD | 168 |
| 65 | F | Virilizing/feminizing | 13.0 | T2NxM0 | R0 | None | No | NA | NA | DOD | 207 |
| 49 | F | Nonsecreting | 9.8 | T2NxM0 | NR | None | No | NA | NA | NED | 125 |
| 50 | F | Nonsecreting | 8 | T2NxM0 | R0 | None | No | NA | NA | DOC | 190 |
| 33 | F | NR | 20.0 | T3NxM0 | NR | None | Spine (distant) | 36.1 | Mitotane and radiation | DOD | 121 |
| 2 | F | Virilizing/feminizing | 19.5 | T3N1M0 | R1 | Cisplatin, VP-16 |
LN (local) | 2.3 | Surgery and chemotherapy |
NED | 166 |
| 32 | F | Virilizing/feminizing | NR | NR | NR | None | Lung (distant) | 4.3 | Surgery only | AWD | 142 |
| 49 | F | Nonsecreting | 13.0 | T3N0M0 | R0 | None | Distal Pancreas (local) |
39.1 | Surgery only | AWD | 149 |
| 42 | F | Nonsecreting | 9.0 | T2NxM0 | NR | None | Liver (local) | 98.4 | Surgery and mitotane | AWD | 150 |
| 55 | M | Nonsecreting | 10.5 | T4N1M1 | NR | None | Liver (local) | 48.5 | Surgery, SBRT, chemotherapy |
AWD | 153 |
NR, not recorded; F, female; M, male; N/A, not applicable; NED, no evidence of disease; DOD, died of disease; DOC, died of other causes; AWD, alive with disease; DFI, disease free interval.